ROK
62
15
TGT
22
2
HCA
44
-2
HON
67
2
LB
63
22
KLAC
47
4
DE
63
3
A
43
2
PGR
65
2
CCI
31
3
SWK
64
5
AXP
71
2
AON
54
2
DD
63
3
BAC
53
3
MSFT
50
3
CPB
30
6
WU
32
2
NDAQ
62
2
CINF
53
2
ROK
62
15
TGT
22
2
HCA
44
-2
HON
67
2
LB
63
22
KLAC
47
4
DE
63
3
A
43
2
PGR
65
2
CCI
31
3
SWK
64
5
AXP
71
2
AON
54
2
DD
63
3
BAC
53
3
MSFT
50
3
CPB
30
6
WU
32
2
NDAQ
62
2
CINF
53
2
Financhill
Back

Novartis AG 10K Form

Buy
62

NVS
Novartis AG

Last Price:
104.27
Seasonality Move:
1.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVS News And Ratings

See the #1 stock for the next 7 days that we like better than NVS

NVS Financial Statistics

Sales & Book Value

Annual Sales: $46.66B
Cash Flow: $5.49B
Price / Cash Flow: 17.1
Annual Sales: $21.67
Price / Book: 4.81

Profitability

EPS (TTM): 8.53000
Net Income (TTM): $17.6B
Gross Margin: $34.19B
Return on Equity: 41.89%
Return on Assets: 17.33%

Novartis AG Earnings Forecast

Key Novartis AG Financial Ratios

  • The Gross Profit Margin over the past 26 years for NVS is 73.27%.
  • The Selling, General & Administrative Expenses for NVS have been equal to 26.83% of Gross Profit Margin.
  • The Research & Development expenses have been 24.37% of Revenue.
  • The Interest Expense is 5.76% of Operating Income.
  • The Net Earning history of NVS is 31.83% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 17 years.

Novartis AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NVS
CUSIP: 66987V
Website: novartis.com

Debt

Debt-to-Equity Ratio: 0.7
Current Ratio: 1.11
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 14.69
Forward P/E Ratio: 12.53

NVS Technical Analysis vs Fundamental Analysis

Buy
62
Novartis AG (NVS) is a Buy

Is Novartis AG a Buy or a Sell?

  • Novartis AG stock is rated a Buy
    The current Novartis AG [NVS] share price is $104.28. The Score for NVS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.